title: Editorial comment. ProPSA and diagnostic biopsy tissue DNA content combination improves accuracy to predict need for prostate cancer treatment among men enrolled in an active surveillance program.
authors.forename: Riccardo
authors.initials: R
authors.lastname: Bartoletti
authors.forename: Tommaso
authors.initials: T
authors.lastname: Cai
mesh_terms: D001707:Biopsy, Needle; D004273:DNA, Neoplasm / Q000032:analysis*; D006801:Humans; D008297:Male; D011467:Prostate / Q000378:metabolism / Q000473:pathology*; D017430:Prostate-Specific Antigen / Q000097:blood*; D011471:Prostatic Neoplasms / Q000175:diagnosis* / Q000628:therapy; D020033:Protein Isoforms / Q000097:blood; D057832:Watchful Waiting
chemical_list: D004273:DNA, Neoplasm; D020033:Protein Isoforms; D017430:Prostate-Specific Antigen